Nuclear Medicine: Page 24

FDA approves Lu-177 PSMA-617 for prostate cancer treatment

By Will Morton

The U.S. Food and Drug Administration (FDA) has approved lutetium-177 (Lu-177) prostate-specific membrane antigen radioligand therapy for the treatment of patients with metastatic prostate cancer.

March 22, 2022

Eckert & Ziegler partners with Alpha-9 Theranostics

By AuntMinnie.com staff writers

Isotope technology firm Eckert & Ziegler has agreed to supply lutetium-177 to the Canadian biotechnology firm Alpha-9 Theranostics for use in clinical trials.

March 22, 2022

Navidea reports revenue declines in Q4, all of 2021

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals reported a decline in revenues for the fourth quarter of 2021 and the entire year.

March 22, 2022

FluoGuide gives details on brain cancer research in Denmark

By AuntMinnie.com staff writers

FluoGuide said a research grant connected to its work with Rigshospitalet in Copenhagen, Denmark, will help it set up a phase II trial for the company's FG001 radiopharmaceutical candidate in patients with less aggressive brain cancers.

March 17, 2022

Tc-99m SPECT/CT imaging detects COVID-19

By Will Morton

Iranian nuclear medicine physicians diagnosed COVID-19 in an asymptomatic patient undergoing technetium-99m (Tc-99m) SPECT/CT imaging for prostate cancer, according to a March 15 report in the Egyptian Journal of Radiology and Nuclear Medicine.

March 17, 2022

Dutch isotope reactor restarts

By AuntMinnie.com staff writers

The High Flux Reactor (HFR) in Petten, the Netherlands, has restarted after a forced shutdown due to a water leak in January, with isotopes deliveries to hospitals expected within two weeks.

March 16, 2022

AC Immune show first images from alpha-synuclein PET

By AuntMinnie.com staff writers

Swiss biopharmaceutical company AC Immune has revealed the first noninvasive live images of alpha-synuclein in humans' brains using its new PET tracer for neurogenerative diseases.

March 15, 2022

IBA and Tractebel partner on construction projects

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) has inked a partnership agreement with engineering company Tractebel to support IBA's customers with their proton therapy design and construction projects.

March 14, 2022

SNMMI names radiopharma therapy centers of excellence

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named its first two designated radiopharmaceutical therapy centers of excellence: Stanford Health Care in Stanford, CA, and the Dana-Farber Brigham Cancer Center in Boston.

March 10, 2022

NorthStar, Convergent ink Ac-225 supply deal

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and Convergent Therapeutics have entered into a supply agreement for the actinium-225 (Ac-225) medical radioisotope.

March 8, 2022

Blue Earth appoints new executives

By AuntMinnie.com staff writers

Blue Earth Diagnostics has appointed David Gauden, PhD, as CEO and Dr. Eugene Teoh as chief medical officer.

February 27, 2022

DMS Health to acquire Nuclear Sonics

By AuntMinnie.com staff writers

DMS Health Technologies has agreed to purchase Nuclear Sonics Associates, a mobile nuclear medicine services provider in Iowa.

February 24, 2022

Previous Page

Page 24 of 439

Next Page